IBB ETF holdings (NASDAQ) - Page 10 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

ABSI Absci Corp. 2.93 M 975.09 K 0.04%

BBOT BridgeBio Oncology Therapeutics, Inc. 2.90 M 324.51 K 0.04%

CATX Perspective Therapeutics, Inc. 2.89 M 693.46 K 0.04%

ACRS Aclaris Therapeutics, Inc. 2.87 M 766.01 K 0.04%

ALT Altimmune, Inc. 2.85 M 926.61 K 0.04%

VNDA Vanda Pharmaceuticals, Inc. 2.80 M 405.04 K 0.03%

ALLO Allogene Therapeutics, Inc. 2.80 M 1.15 M 0.03%

RGNX REGENXBIO, Inc. 2.78 M 331.42 K 0.03%

RCKT Rocket Pharmaceuticals, Inc. 2.69 M 752.57 K 0.03%

PACB Pacific Biosciences of California, Inc. 2.67 M 2.02 M 0.03%

LXEO Lexeo Therapeutics, Inc. 2.63 M 457.45 K 0.03%

ALVO Alvotech SA 2.62 M 763.48 K 0.03%

CTNM Contineum Therapeutics, Inc. 2.62 M 200.36 K 0.03%

ENTA Enanta Pharmaceuticals, Inc. 2.59 M 205.18 K 0.03%

LCTX Lineage Cell Therapeutics, Inc. 2.56 M 1.62 M 0.03%

LAB Standard BioTools, Inc. 2.53 M 2.75 M 0.03%

ADCT ADC Therapeutics SA 2.52 M 673.14 K 0.03%

DSGN Design Therapeutics, Inc. 2.51 M 235.86 K 0.03%

PSNL Personalis, Inc. 2.50 M 393.15 K 0.03%

AVIR Atea Pharmaceuticals, Inc. 2.48 M 460.06 K 0.03%

1
...
6
7
8
9
10
11
12
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026